CB Medical Holdings and Biosensors International Group $817 million merger

Overview:

• CB Medical Holdings has undertaken a $817 million privatisation process of Biosensors International Group by way of amalgamation.
• This deal represents the first amalgamation on the Singapore Stock Exchange.
• Bermuda-based investment holding company CB Medical is part of China’s state-owned CITIC Group.
• Morgan Stanley Asia and DBS Bank have acted as joint financial advisers to CB Medical Holdings. 

Katrin Kostadinova - Data analyst